Patents Assigned to GENDIAG.EXE, S.L.
-
Patent number: 10557170Abstract: The invention relates to a method for a more appropriate thromboembolic event risk assessment based on the presence of different genetic variant. The invention also relates to a method for determining the risk of suffering a thromboembolism disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for thromboembolism as well as computer-implemented means for carrying out said method.Type: GrantFiled: July 17, 2017Date of Patent: February 11, 2020Assignee: Gendiag.exe, S.L.Inventors: Eduardo Salas, José Manuel Soria, Miroslava Ogorelkova, Roberto Elosua Llanos, Joan Vila, Sergio Castillo Fernandez
-
Patent number: 10023914Abstract: The invention relates to a method for a more appropriate thromboembolic event risk assessment based on the presence of different genetic variant. The invention also relates to a method for determining the risk of suffering a thromboembolism disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for thromboembolism as well as computer-implemented means for carrying out said method.Type: GrantFiled: October 19, 2015Date of Patent: July 17, 2018Assignee: Gendiag.exe, S.L.Inventors: Eduardo Salas, José Manuel Soria, Miroslava Ogorelkova, Roberto Elosua, Joan S. Vila, Sergio Castillo
-
Patent number: 9957565Abstract: The invention relates to a method for determining the risk of suffering a cardiovascular disease based on the presence of different polymorphisms as well as to kits for practicing the above method. The invention also relates to a method for determining the risk of suffering a cardiovascular disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for CVD as well as computer-implemented means for carrying out said method.Type: GrantFiled: June 9, 2010Date of Patent: May 1, 2018Assignee: Gendiag.exe, S.L.Inventors: Eduardo Salas Pérez-Rasilla, Jaume Marrugat De La Iglesia, Roberto Elosua Llanos, Sergio Castillo Fernandez, Joan Salgado Gómez, Jose Maria Ordovás Munoz
-
Publication number: 20180066313Abstract: The invention relates to a method for a more appropriate thromboembolic event risk assessment based on the presence of different genetic variant. The invention also relates to a method for determining the risk of suffering a thromboembolism disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for thromboembolism as well as computer-implemented means for carrying out said method.Type: ApplicationFiled: July 17, 2017Publication date: March 8, 2018Applicant: Gendiag.exe, S.L.Inventors: Eduardo Salas, José Manuel Soria, Miroslava Ogorelkova, Roberto Elosua Llanos, Joan Vila, Sergio Castillo Fernandez
-
Patent number: 9518297Abstract: The invention relates to a method for a more appropriate thromboembolic event risk assessment based on the presence of different genetic variant. The invention also relates to a method for determining the risk of suffering a thromboembolism disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for thromboembolism as well as computer-implemented means for carrying out said method.Type: GrantFiled: June 13, 2012Date of Patent: December 13, 2016Assignee: Gendiag.exe, S.L.Inventors: Eduardo Salas, José Manuel Soria, Miroslava Ogorelkova, Roberto Elosua Llanos, Joan Vila, Sergio Castillo
-
Publication number: 20160215341Abstract: The invention relates to a method for determining the risk of a subject suffering from chronic kidney disease of suffering a cardiovascular disease based on the presence of different polymorphisms as well as to kits for practicing the above method. The invention also relates to a method for determining the risk of suffering a cardiovascular disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with clinical/biochemical risk factors for CVD as well as computer-implemented means for carrying out said method.Type: ApplicationFiled: August 29, 2014Publication date: July 28, 2016Applicant: Gendiag.exe, S.L.Inventors: Eduardo Salas, Sara Pich, Manuel Arias, Roberto Elosua, Sergio Castillo
-
Publication number: 20160102355Abstract: The invention relates to a method for a more appropriate thromboembolic event risk assessment based on the presence of different genetic variant. The invention also relates to a method for determining the risk of suffering a thromboembolism disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for thromboembolism as well as computer-implemented means for carrying out said method.Type: ApplicationFiled: October 19, 2015Publication date: April 14, 2016Applicant: Gendiag.exe, S.L.Inventors: Eduardo Salas, José Manuel Soria, Miroslava Ogorelkova, Roberto Elosua Llanos, Joan Vila, Sergio Castillo Fernandez
-
Publication number: 20140342355Abstract: The invention relates to a method for the reclassification of a subject to a more appropriate risk assessment to that obtained using the algorithms for such risk estimation such us but not limited to Framingham, Regicor, Score, Procamor Qrisk based on the presence of different polymorphisms. The invention also relates to a method for determining the risk of suffering a cardiovascular disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for CVD as well as computer-implemented means for carrying out said method.Type: ApplicationFiled: August 1, 2012Publication date: November 20, 2014Applicant: Gendiag.exe, S.L.Inventors: Eduardo Salas Pérez-Rasilla, Jaume Marrrugat De La Iglesia, Roberto Elosua Llanos, Sergio Castillo Fernández, Joan Salgado Gómez, José Maria Ordovás Munoz
-
Publication number: 20140221230Abstract: The invention relates to a method for a more appropriate thromboembolic event risk assessment based on the presence of different genetic variant. The invention also relates to a method for determining the risk of suffering a thromboembolism disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for thromboembolism as well as computer-implemented means for carrying out said method.Type: ApplicationFiled: June 13, 2012Publication date: August 7, 2014Applicant: Gendiag.exe, S.L.Inventors: Eduardo Salas, José Manuel Soria, Miroslava Ogorelkova, Roberto Elosua Llanos, Joan Vila, Sergio Castillo
-
Publication number: 20120141450Abstract: The invention relates to a method for determining the risk of suffering a cardiovascular disease based on the presence of different polymorphisms as well as to kits for practicing the above method. The invention also relates to a method for determining the risk of suffering a cardiovascular disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for CVD as well as computer-implemented means for carrying out said method.Type: ApplicationFiled: June 9, 2010Publication date: June 7, 2012Applicant: GENDIAG.EXE, S.L.Inventors: Eduardo Salas Pérez-Rasilla, Jaume Marrugat De La Iglesia, Roberto Elosua Llanos, Sergio Castillo Fernandez, Joan Salgado Gómez, Jose Maria Ordovás Munoz